» Articles » PMID: 11865067

Activated Fes Protein Tyrosine Kinase Induces Terminal Macrophage Differentiation of Myeloid Progenitors (U937 Cells) and Activation of the Transcription Factor PU.1

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 2002 Feb 28
PMID 11865067
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

The c-fps/fes proto-oncogene encodes a 92-kDa protein tyrosine kinase that is preferentially expressed in myeloid and endothelial cells. Fes is believed to play a role in vascular development and myelopoiesis and in the inflammatory responses of granulocytes and macrophages. To help define the biological role of this kinase and identify its downstream targets, we have developed a gain-of-function allele of Fes that has potent biological activity in myeloid cell progenitors. Introduction of constitutively active Fes into bipotential U937 cells induced the appearance of fully differentiated macrophages within 6 to 12 days. The Fes-expressing differentiated cells became adherent, had distinctive macrophage morphology, and exhibited increased expression of myelomonocytic differentiation markers, including CD11b, CD11c, CD18, CD14, and the macrophage colony-stimulating factor receptor. These cells acquired phagocytic properties and exhibited NADPH oxidase and nonspecific esterase activities, confirming that they were functionally active macrophages. Concomitantly, there was downregulation of the granulocytic marker granulocyte colony-stimulating factor receptor, indicating that the biological activity of Fes was coordinated in a lineage-specific manner. A constitutively active Src did not induce macrophage morphology or upregulation of myelomonocytic markers in U937 cells, suggesting that the biological activity we observed was not a general consequence of expression of an activated nonreceptor tyrosine kinase. Analysis of possible downstream targets of Fes revealed that this kinase activated the ets family transcription factor PU.1, which is essential for macrophage development. Our results strongly implicate Fes as a key regulator of terminal macrophage differentiation and identify PU.1 as a transcription factor that may mediate some of its biological activities in myeloid cells.

Citing Articles

Chemical genetics strategy to profile kinase target engagement reveals role of FES in neutrophil phagocytosis.

van der Wel T, Hilhorst R, den Dulk H, van den Hooven T, Prins N, Wijnakker J Nat Commun. 2020; 11(1):3216.

PMID: 32587248 PMC: 7316778. DOI: 10.1038/s41467-020-17027-5.


Development of a Sox2 reporter system modeling cellular heterogeneity in glioma.

Stoltz K, Sinyuk M, Hale J, Wu Q, Otvos B, Walker K Neuro Oncol. 2014; 17(3):361-71.

PMID: 25416826 PMC: 4483103. DOI: 10.1093/neuonc/nou320.


Small-molecule inhibitors of the c-Fes protein-tyrosine kinase.

Hellwig S, Miduturu C, Kanda S, Zhang J, Filippakopoulos P, Salah E Chem Biol. 2012; 19(4):529-40.

PMID: 22520759 PMC: 3334838. DOI: 10.1016/j.chembiol.2012.01.020.


Fes tyrosine kinase expression in the tumor niche correlates with enhanced tumor growth, angiogenesis, circulating tumor cells, metastasis, and infiltrating macrophages.

Zhang S, Chitu V, Stanley E, Elliott B, Greer P Cancer Res. 2010; 71(4):1465-73.

PMID: 21159660 PMC: 3041852. DOI: 10.1158/0008-5472.CAN-10-3757.


Bimolecular fluorescence complementation demonstrates that the c-Fes protein-tyrosine kinase forms constitutive oligomers in living cells.

Shaffer J, Hellwig S, Smithgall T Biochemistry. 2009; 48(22):4780-8.

PMID: 19382747 PMC: 3222594. DOI: 10.1021/bi900238f.


References
1.
Yu G, Smithgall T, Glazer R . K562 leukemia cells transfected with the human c-fes gene acquire the ability to undergo myeloid differentiation. J Biol Chem. 1989; 264(17):10276-81. View

2.
Harrison D, Binari R, Nahreini T, Gilman M, Perrimon N . Activation of a Drosophila Janus kinase (JAK) causes hematopoietic neoplasia and developmental defects. EMBO J. 1995; 14(12):2857-65. PMC: 398404. DOI: 10.1002/j.1460-2075.1995.tb07285.x. View

3.
Senis Y, Zirngibl R, McVeigh J, Haman A, Hoang T, Greer P . Targeted disruption of the murine fps/fes proto-oncogene reveals that Fps/Fes kinase activity is dispensable for hematopoiesis. Mol Cell Biol. 1999; 19(11):7436-46. PMC: 84737. DOI: 10.1128/MCB.19.11.7436. View

4.
Nagulapalli S, Pongubala J, Atchison M . Multiple proteins physically interact with PU.1. Transcriptional synergy with NF-IL6 beta (C/EBP delta, CRP3). J Immunol. 1995; 155(9):4330-8. View

5.
Metcalf D . The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells. Nature. 1989; 339(6219):27-30. DOI: 10.1038/339027a0. View